Purchase Order 36C26023P0470

Award Date 7/1/23
Potential Completion Date 6/30/28
Potential Value $38K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98108, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs Veterans Health Administration to the Fred Hutchinson Cancer Research Center, a non-profit organization. The $34,104.22 contract is for genomics DNA/RNA sequencing services to support research and development at the VA Puget Sound Health Care System in Seattle, WA. The contract has a completion date of April 20, 2023 and was awarded on April 21, 2021. This contract does not have a set-aside designation....
This is a firm fixed price definitive contract awarded by the Department of Veterans Affairs Veterans Health Administration (VA VHA) to the Fred Hutchinson Cancer Research Center, a non-profit organization, for $364,153.24 in research services. The contract has a completion date of September 29, 2022 and was originally awarded on September 30, 2018. The work is being performed in Seattle, WA. The prime contractor, Fred Hutchinson Cancer Research Center, has provided a range of research...
This is a $1,899,029.00 Firm Fixed Price Delivery Order awarded by the National Cancer Institute to the Fred Hutchinson Cancer Center, doing business as the Seattle Cancer Care Alliance. The contract supports the SEER*EDUCATE Base Award, which is part of the Surveillance Epidemiology and End Results (SEER) Contract vehicle. The place of performance is Seattle, WA, and the period of performance runs through August 16, 2028. No set-aside designation was used. The Fred Hutchinson Cancer Center is a...
This firm fixed price delivery order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Fred Hutchinson Cancer Research Center, a non-profit organization, to provide core support services and DNA extraction services in support of VHA medical programs operated through the regional VISN 20 network in Seattle, WA. The contract has a ceiling value of $3,501.73 and an ultimate completion date of September 29, 2024. This is a new delivery order issued...
This is a firm fixed price delivery order contract awarded to Fred Hutchinson Cancer Research Center, a non-profit organization, by the U.S. Department of Veterans Affairs (VA) under an Indefinite Delivery Contract (IDC). The contract is for DNA extraction services to support the VA's Veterans Health Administration (VHA) medical programs operated through the regional Veterans Integrated Service Network 20 (VISN 20) in Seattle, Washington. The contract has a ceiling value of $82,816.00 and a...
This is a firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency, to the Fred Hutchinson Cancer Research Center, a non-profit organization. The $52,423 contract is part of the NCI's Surveillance, Epidemiology, and End Results (SEER) program and is intended to improve the completeness of treatment and other key data elements by linking 15-month resubmitted data from Commission on Cancer (CoC) hospitals. The contract has an ultimate completion...
This $5,635,564.60 cost-reimbursable definitive contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Fred Hutchinson Cancer Center (doing business as Seattle Cancer Care Alliance), a non-profit medical research organization. The contract supports targeted clinical research to address select viral infections. There was no set-aside designation. Under the contract, Fred Hutchinson Cancer Center is...
This is a federal contract awarded by the National Cancer Institute, a civilian agency, to the Fred Hutchinson Cancer Research Center, a non-profit organization. The contract, with a ceiling value of $96,829,521.71, is a definitive contract with a cost-no-fee pricing type. It is not a set-aside contract. The contract is for "CONTRACT INFORMATION SERVICE" and will be performed in Seattle, WA. Fred Hutchinson Cancer Research Center is a prime contractor that has also received federal...
This is a $441,755.09 firm fixed price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration to the Fred Hutchinson Cancer Research Center, a non-profit organization, to conduct a smoking cessation research program focused on effective counseling techniques to help veterans stop smoking. The work will be performed in Seattle, Washington and the period of performance runs through March 31, 2023. This contract was not set aside for any specific...
This is a firm fixed price delivery order awarded by the National Cancer Institute (NCI) to the Fred Hutchinson Cancer Research Center, a non-profit organization. The contract is part of the NCI's Surveillance, Epidemiology, and End Results (SEER) Expansion Program and has a period of performance from August 15, 2016 to August 14, 2017 with a ceiling value of $81,968.00. The contract is for a Patterns of Care/Quality of Care Study related to the diagnosis year 2015, and does not have a set-aside...

This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration to the Fred Hutchinson Cancer Center, doing business as the Seattle Cancer Care Alliance, a non-profit medical research organization. The contract is for $38,112.35 and provides for genomic sequencing services to be performed in Seattle, Washington through June 30, 2028. No set-aside designation was indicated. The Fred Hutchinson Cancer Center has previously performed research, coordination, and medical services under various federal contracts and grants, including from the National Institutes of Health, Department of Defense, and others, across areas such as cancer, infectious diseases, and COVID-19 vaccine trials.

Generated 4/5/24, 10:01 AM